General Information of the Ferroptosis Regulator (ID: REG20123)
Regulator Name hsa-miR-372-3p (miRNA)
Synonyms
hsa-miR-372-3p
    Click to Show/Hide
Gene Name hsa-miR-372-3p
Regulator Type miRNA
MiRBase ID MIMAT0000724
Sequence
AAAGUGCUGCGACAUUUGAGCGU

    Click to Show/Hide
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-372-3p can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Cystine/glutamate transporter (SLC7A11) [Driver; Suppressor]
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis Target of This Regulator [1]
Target for Ferroptosis Suppressor
Responsed Disease Oesophageal cancer ICD-11: 2B70
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model
EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
4F2 cell-surface antigen heavy chain (SLC3A2) [Suppressor]
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis Target of This Regulator [1]
Target for Ferroptosis Suppressor
Responsed Disease Oesophageal cancer ICD-11: 2B70
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model
EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Oesophageal cancer [ICD-11: 2B70]
In total 2 item(s) under this disease
Experiment 1 Reporting the Ferroptosis-centered Disease Response [1]
Target Regulator hsa-miR-372-3p (miRNA) miRNA
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model
EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Experiment 2 Reporting the Ferroptosis-centered Disease Response [1]
Target Regulator hsa-miR-372-3p (miRNA) miRNA
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model
EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
References
Ref 1 Mechanism and Role of the Neuropeptide LGI1 Receptor ADAM23 in Regulating Biomarkers of Ferroptosis and Progression of Esophageal Cancer. Dis Markers. 2021 Dec 30;2021:9227897. doi: 10.1155/2021/9227897. eCollection 2021.